1. Kotton CN, Kumar D, Manuel O, et al. The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation. Transplantation. 2025;109:1066-
1110.
2. Gerna G, Lilleri D, Zecca M, et al. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant
recipients. Haematologica. 2005;90:526-533.
3. Khawaja F, Zamora D, Yong MK, et al. American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and
Cellular Therapy Recipients. Transplant Cell Ther 2025;31:727-741.
4. Piñana JL, Giménez E, Vázquez L, et al. Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the
Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC). Mediterr J Hematol Infect Dis 2024;16:e2024065.
5. Ljungman P, Alain S, Chemaly RF, et al. Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic
haematopoietic cell transplantation and other T-cell-engaging therapies. Lancet Infect Dis. 2025;25:e451-e462.
6. Hayden RT, Preiksaitis J, Tong Y, et al. Commutability of the First World Health Organization International Standard for Human Cytomegalovirus. J Clin Microbiol 2015;53:3325-33.
7. Çolak D, Sağlık İ, Can Sarınoğlu R, ve ark. Dünya Sağlık Örgütü Uluslararası Sitomegalovirüs (CMV) Standardı ile Kalibre Edilmiş İki Ticari Kantitatif CMV Polimeraz Zincir Reaksiyonu
Testinin Karşılaştırılması. Mikrobiyol Bul. 2020;54:257-265.
8. Bozdemir T, Daloğlu AE, Çolak D, Gürkan N, Öngüt G, Mutlu D. Tam Otomatize Sistemlerde Çalışılan Sitomegalovirüs Polimeraz Zincir Reaksiyonu Test Sonuçlarının Karşılaştırılması:
Roche Cobas 6800 ile Qiagen NeuMoDx Deneyimi. Mikrobiyol Bul. 2024;58:284-292.
9. Boom R, Sol CJA, Schuurman T, Van Breda A, Weel JFL, Beld M, Ten Berge IJM, Wertheim-Van Dillen PME, De Jong MD. 2002. Human cytomegalovirus DNA in plasma and serum speci-
mens of renal transplant recipients is highly fragmented. J Clin Microbiol 40:4105–4113.
10. Leuzinger K, Hirsch HH. Amplicon size and non-encapsidated DNA fragments define plasma cytomegalovirus DNA loads by automated nucleic acid testing platforms: a marker of viral
cytopathology? J Med Virol. 2023;95:e29139.
11. Peddu V, Bradley BT, Casto AM, et al. High-resolution profiling of human cytomegalovirus cell-free DNA in human plasma highlights its exceptionally fragmented nature. Sci Rep.
2020;10:3734.
12. Kraft CS, Armstrong WS, Caliendo AM. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis. 2012;54:1793-1800.
13. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013;26:703-727.
14. Allen UD, Preiksaitis JK; AST Infectious Diseases Community of Practice. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplanta-
tion: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13652.
15. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;Suppl
3:S1-155.
16. Fulchiero R, Amaral S. Post-transplant lymphoproliferative disease after pediatric kidney transplant. Front Pediatr 2022;10:1087864.
17. Styczynski J, van der Velden W, Fox CP, e al. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem
cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica. 2016;101:803-811.
18. Kotton CN, Kamar N, Wojciechowski D, et al. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation. Transplantation.
2024;108:1834-1866.
19. Hassan S, Mittal C, Amer S, et al. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/ml underestimates the diagnosis of BKV-associated nephropathy: a single
transplant center experience. Transpl Infect Dis. 2014;16:55-60.
20. Bateman AC, Greninger AL, Atienza EE, Limaye AP, Jerome KR, Cook L. Quantification of BK Virus Standards by Quantitative Real-Time PCR and Droplet Digital PCR Is Confounded by
Multiple Virus Populations in the WHO BKV International Standard. Clin Chem. 2017;63:761-769.
21. Erman Daloğlu A, Mutlu D, Sağlık İ, ve ark. BK Virüs (BKV) Kantitasyonunda Kullanılan İki Farklı Gerçek Zamanlı Polimeraz Zincir Reaksiyonu Yönteminin Karşılaştırması ve BKV Genotip
Tayini. Mikrobiyol Bul. 2019;53:285-296.
22. Cesaro S, Dalianis T, Hanssen Rinaldo C, et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell
transplant recipients. J Antimicrob Chemother. 2018;73:12-21.
23. Jandial A, Mishra K, Sandal R, Kant Sahu K. Management of BK virus-associated haemorrhagic cystitis in allogeneic stem cell transplant recipients. Ther Adv Infect Dis. 2021 Feb
3;8:2049936121991377.
24. Akarca U, Baykam, N, Güner R ve ark. Türkiye Hepatit B Tanı ve Tedavi Kılavuzu 2023:20-21
25. Mikulska M, van Bömmel F, Mouliade C, et al. Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those
undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9). Lancet Haematol. 2025;12:e389-e399.
26. Wolfe CR, Ison MG; AST Infectious Diseases Community of Practice. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of
Practice. Clin Transplant. 2019;33:e13547.
27. Center for Disease Control and Prevention (2025). Getting testing for HIV. www.cdc.gov/hiv/testing/index.html
28. Matthes-Martin S, Feuchtinger T, Shaw PJ, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4
(2011). Transpl Infect Dis. 2012;14:555-563.
29. Florescu DF, Schaenman JM; AST Infectious Diseases Community of Practice. Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation
Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13527.
30. Schiemann M, Puchhammer-Stöckl E, Eskandary F, et al. Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation. Transplantation
2017;101:360-367.
31. Maggi F, Focosi D, Statzu M, et al. Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients Sci Rep 2018;8:15490.
32. Peker BO, Daloğlu AE, Görzer I, et al.Investigation of Torque Teno Virus (TTV) DNA as an immunological and virological marker in pediatric hematopoietic stem cell transplantation
(HSCT) patients. Microb Pathog 2020;149:104397.
33. Jaksch P, Görzer I, Puchhammer-Stöckl E, Bond G. Integrated Immunologic Monitoring in Solid Organ Transplantation: The Road Toward Torque Teno Virus-guided Immunosuppression.
Transplantation 2022;106:1940-1